JenaValve, a German medical device company that focuses on the implant of new aortic valves, has raised a hefty €19m from in a series B round of financing. Belgian private equity firm led the round and was joined by Atlas Venture, Edmond de Rothschild Investment Partners, Neomed Management, VI Partners and Sunstone Capital.
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Become a Premium SubscriberIf you are already a AltAssets subscriber please log in below.